In this COVID-19 clinical update, Daniel Griffin summarizes current status of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the use of Ct values in patient management.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Argentine study on plasma therapy (NEJM)
- Ct values and clinical outcome (Open Forum Inf Dis)
- Bamlanivimab fact sheet (FDA pdf)
- Cognitive defects in recovered COVID-19 patients (medRxiv)
- Letters read on TWiV 704
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
